TY - JOUR
T1 - In Vitro Biosynthesis of the Core Scaffold of the Thiopeptide Thiomuracin
AU - Hudson, Graham A.
AU - Zhang, Zhengan
AU - Tietz, Jonathan I.
AU - Mitchell, Douglas A.
AU - Van Der Donk, Wilfred A.
N1 - Publisher Copyright:
© 2015 American Chemical Society.
PY - 2015/12/30
Y1 - 2015/12/30
N2 - Thiopeptides are potent antibiotics that inhibit protein synthesis. They are made by a remarkable post-translational modification process that transforms a linear peptide into a polycyclic structure. We present here the in vitro biosynthesis of the core scaffold of thiomuracin catalyzed by six proteins. We show that cyclodehydration precedes dehydration, and that dehydration is catalyzed by two proteins in a tRNAGlu-dependent manner. The enzyme that generates the pyridine core from two dehydroalanines ejects the leader peptide as a C-terminal carboxamide. Mutagenesis studies of the enzyme TbtD identified important residues for a formal [4+2] cycloaddition process. The core structure of thiomuracin exhibits similar antimicrobial activity to other known congeners, illustrating that in vitro biosynthesis is a viable route to potent antibiotics that can be explored for the rapid and renewable generation of analogues.
AB - Thiopeptides are potent antibiotics that inhibit protein synthesis. They are made by a remarkable post-translational modification process that transforms a linear peptide into a polycyclic structure. We present here the in vitro biosynthesis of the core scaffold of thiomuracin catalyzed by six proteins. We show that cyclodehydration precedes dehydration, and that dehydration is catalyzed by two proteins in a tRNAGlu-dependent manner. The enzyme that generates the pyridine core from two dehydroalanines ejects the leader peptide as a C-terminal carboxamide. Mutagenesis studies of the enzyme TbtD identified important residues for a formal [4+2] cycloaddition process. The core structure of thiomuracin exhibits similar antimicrobial activity to other known congeners, illustrating that in vitro biosynthesis is a viable route to potent antibiotics that can be explored for the rapid and renewable generation of analogues.
UR - http://www.scopus.com/inward/record.url?scp=84953439957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84953439957&partnerID=8YFLogxK
U2 - 10.1021/jacs.5b10194
DO - 10.1021/jacs.5b10194
M3 - Article
C2 - 26675417
AN - SCOPUS:84953439957
SN - 0002-7863
VL - 137
SP - 16012
EP - 16015
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 51
ER -